|
|
Line 5: |
Line 5: |
| <div class="container"> | | <div class="container"> |
| <div id="title" style="background-image: url(https://static.igem.org/mediawiki/2017/4/4a/T--Bielefeld-CeBiTec--title-img-nanopore.jpg);"> | | <div id="title" style="background-image: url(https://static.igem.org/mediawiki/2017/4/4a/T--Bielefeld-CeBiTec--title-img-nanopore.jpg);"> |
− | <img src="https://static.igem.org/mediawiki/2017/4/4a/T--Bielefeld-CeBiTec--title-img-nanopore.jpg">
| + | <img src="https://static.igem.org/mediawiki/2017/4/4a/T--Bielefeld-CeBiTec--title-img-nanopore.jpg"> |
− | <div id="title-bg">
| + | <div id="title-bg"> |
− | <div id="title-text">
| + | <div id="title-text"> |
− | Development of New Methods
| + | Development of New Methods |
− | </div>
| + | </div> |
− | </div>
| + | </div> |
− | </div>
| + | </div> |
| | | |
| | | |
Line 61: |
Line 61: |
| For good annealing efficiency, it is necessary to add the two oligo strands together in equal molar amounts. The concentration can be calculated by the OD<sub>260</sub> value, while an OD<sub>260</sub> of 1 equals 33 µg ml<sup>-1</sup> <a href=" https://nebiocalculator.neb.com/#!/od260"> (NEB calculator, September 2017) </a> and the molecular mass of each oligo. | | For good annealing efficiency, it is necessary to add the two oligo strands together in equal molar amounts. The concentration can be calculated by the OD<sub>260</sub> value, while an OD<sub>260</sub> of 1 equals 33 µg ml<sup>-1</sup> <a href=" https://nebiocalculator.neb.com/#!/od260"> (NEB calculator, September 2017) </a> and the molecular mass of each oligo. |
| | | |
− | <div class="equation-line">
| + | <div class="equation-line"> |
− | <img class="equation" src="https://static.igem.org/mediawiki/2017/a/a3/T--Bielefeld-CeBiTec--Formel_Molmass.png" style="width:500px;">
| + | <img class="equation" src="https://static.igem.org/mediawiki/2017/a/a3/T--Bielefeld-CeBiTec--Formel_Molmass.png" style="width:500px;"> |
− | <p class="equation-nr">(1)</p>
| + | <p class="equation-nr">(1)</p> |
− | </div>
| + | </div> |
| | | |
| | | |
| <!-- Grosses zentriertes Bild --> | | <!-- Grosses zentriertes Bild --> |
− | <div class="figure large">
| + | <div class="figure large"> |
− | <img class="figure image" src="https://static.igem.org/mediawiki/2017/7/75/T--Bielefeld-CeBiTec--MAX_sequences.jpg">
| + | <img class="figure image" src="https://static.igem.org/mediawiki/2017/7/75/T--Bielefeld-CeBiTec--MAX_sequences.jpg"> |
− | <p class="figure subtitle"><b>Figure 1:</b>Sequenzes of M.A.X targets mutA, mutT, mutG ad mutC with relevant restriction sites as well as the sequence of UBP_target.</p>
| + | <p class="figure subtitle"><b>Figure 1:</b>Sequenzes of M.A.X targets mutA, mutT, mutG ad mutC with relevant restriction sites as well as the sequence of UBP_target.</p> |
− | </div>
| + | </div> |
| | | |
| | | |
Line 79: |
Line 79: |
| | | |
| <br>After first results, a final annealing concentration of 0.5 µmol L<sup>-1</sup> seems to be a good choice in terms of visibility and low DNA quantity for complete digestion. For the following annealing reactions, 1 µmol L<sup>-1</sup> of ssDNA was used to get 0.5 µL L<sup>-1</sup> of annealed dsDNA. | | <br>After first results, a final annealing concentration of 0.5 µmol L<sup>-1</sup> seems to be a good choice in terms of visibility and low DNA quantity for complete digestion. For the following annealing reactions, 1 µmol L<sup>-1</sup> of ssDNA was used to get 0.5 µL L<sup>-1</sup> of annealed dsDNA. |
− | </br> | + | </br> |
− | </article>
| + | </article> |
− | <h4>Restriction digest</h4>
| + | <h4>Restriction digest</h4> |
− |
| + | |
− | <article>
| + | <article> |
− | <br>The DNA strands were designed such that the partial restriction sites of four different restriction enzymes are located at the same position. In case of a mutation, we can validate to which base the unnatural base mutated without sequencing it. To test the practicability and quality of the restriction system, we performed several test restriction digests. </br>
| + | <br>The DNA strands were designed such that the partial restriction sites of four different restriction enzymes are located at the same position. In case of a mutation, we can validate to which base the unnatural base mutated without sequencing it. To test the practicability and quality of the restriction system, we performed several test restriction digests. </br> |
| <br>To ensure the digestion is complete, we calculated the amount of DNA which is digested per unit of enzyme in 1 hour at 37 °C. 1 unit is defined as the amount of restriction enzyme needed to digest 1 µg of lambda DNA. The lambda DNA consists of 48,502 bp <a href=" https://www.neb.com/products/n3011-lambda-dna#Product%20Information"> (NEB) </a>, which equals 1.99 ∙ 10<sup>10</sup> molecules per µL. Depending on the sum of recognition sites of each enzyme, we calculated the cuts per hour of each enzyme. | | <br>To ensure the digestion is complete, we calculated the amount of DNA which is digested per unit of enzyme in 1 hour at 37 °C. 1 unit is defined as the amount of restriction enzyme needed to digest 1 µg of lambda DNA. The lambda DNA consists of 48,502 bp <a href=" https://www.neb.com/products/n3011-lambda-dna#Product%20Information"> (NEB) </a>, which equals 1.99 ∙ 10<sup>10</sup> molecules per µL. Depending on the sum of recognition sites of each enzyme, we calculated the cuts per hour of each enzyme. |
− | </br>
| + | </br> |
− | <!-- Tabelle mit Tabellenueberschrift
| + | <!-- Tabelle mit Tabellenueberschrift |
− | Soviele Spalten wie es geben soll, so viele <th>'s muessen im thead und <td>'s -->
| + | Soviele Spalten wie es geben soll, so viele <th>'s muessen im thead und <td>'s --> |
− | <p class="table-headline"><b>Table 1:</b> Calculation of restrictions per hour (1 unit) of the M.A.X enzymes.</p>
| + | <p class="table-headline"><b>Table 1:</b> Calculation of restrictions per hour (1 unit) of the M.A.X enzymes.</p> |
− | <table>
| + | <table> |
− | <thead>
| + | <thead> |
− | <tr>
| + | <tr> |
− | <th style="width: auto"></th>
| + | <th style="width: auto"></th> |
− | <th style="width: auto">Enzyme</th>
| + | <th style="width: auto">Enzyme</th> |
− | <th style="width: auto">unit per µL</th>
| + | <th style="width: auto">unit per µL</th> |
− | <th style="width: auto">restriction sites in lambda DNA</th>
| + | <th style="width: auto">restriction sites in lambda DNA</th> |
− | <th style="width: auto">restriction per hour (1 unit)</th>
| + | <th style="width: auto">restriction per hour (1 unit)</th> |
− | </tr>
| + | </tr> |
− | </thead>
| + | </thead> |
− | <tbody>
| + | <tbody> |
− |
| + | |
− | <tr>
| + | <tr> |
− | <td align="center">mutG</td>
| + | <td align="center">mutG</td> |
− | <td align="center"><i>Sap</i>I</td>
| + | <td align="center"><i>Sap</i>I</td> |
− | <td align="center">10</td>
| + | <td align="center">10</td> |
− | <td align="center">10</td>
| + | <td align="center">10</td> |
− | <td align="center">1.99∙10<sup>12</sup></td>
| + | <td align="center">1.99∙10<sup>12</sup></td> |
− |
| + | |
− | </tr>
| + | </tr> |
− |
| + | |
− | <tr>
| + | <tr> |
− | <td align="center">mutC</td>
| + | <td align="center">mutC</td> |
− | <td align="center"><i>Mnl</i>I</td>
| + | <td align="center"><i>Mnl</i>I</td> |
− | <td align="center">5</td>
| + | <td align="center">5</td> |
− | <td align="center">262</td>
| + | <td align="center">262</td> |
− | <td align="center">2.35∙10<sup>13</sup></td>
| + | <td align="center">2.35∙10<sup>13</sup></td> |
− | </tr>
| + | </tr> |
− |
| + | |
− | <tr>
| + | <tr> |
− | <td align="center">mutT</td>
| + | <td align="center">mutT</td> |
− | <td align="center"><i>Bsa</i>I</td>
| + | <td align="center"><i>Bsa</i>I</td> |
− | <td align="center">10</td>
| + | <td align="center">10</td> |
− | <td align="center">2</td>
| + | <td align="center">2</td> |
− | <td align="center">3.6∙10<sup>11</sup></td>
| + | <td align="center">3.6∙10<sup>11</sup></td> |
− | </tr>
| + | </tr> |
− |
| + | |
− | <tr>
| + | <tr> |
− | <td align="center">mutA</td>
| + | <td align="center">mutA</td> |
− | <td align="center"><i>Eci</i>I</td>
| + | <td align="center"><i>Eci</i>I</td> |
− | <td align="center">2</td>
| + | <td align="center">2</td> |
− | <td align="center">29</td>
| + | <td align="center">29</td> |
− | <td align="center">1.44∙10<sup>12</sup></td>
| + | <td align="center">1.44∙10<sup>12</sup></td> |
− | </tr>
| + | </tr> |
− | </tbody>
| + | </tbody> |
− | </table>
| + | </table> |
| | | |
− | <br>In an annealing reaction with 0.5 µmol L<sup>-1</sup> DNA in a total reaction volume of 50 µL, we have 3.011 ∙ 10<sup>8</sup> molecules per µL, each contain one or two restriction site. Theoretically, more than 1 mL of the annealing DNA should be digested by 1 unit of restriction enzyme per hour. After 1 hour of incubation and following heat inactivation, all samples were resolves by electrophoresis using a 12 % bisacrlyamid <a target="_blank"href="https://static.igem.org/mediawiki/2017/e/e6/T--Bielefeld-CeBiTec--protocol_native_PAGE.pdf">Native DNA PAGE</a>.
| + | <br>In an annealing reaction with 0.5 µmol L<sup>-1</sup> DNA in a total reaction volume of 50 µL, we have 3.011 ∙ 10<sup>8</sup> molecules per µL, each contain one or two restriction site. Theoretically, more than 1 mL of the annealing DNA should be digested by 1 unit of restriction enzyme per hour. After 1 hour of incubation and following heat inactivation, all samples were resolves by electrophoresis using a 12 % bisacrlyamid <a target="_blank"href="https://static.igem.org/mediawiki/2017/e/e6/T--Bielefeld-CeBiTec--protocol_native_PAGE.pdf">Native DNA PAGE</a>. |
− | </br>
| + | </br> |
− |
| + | |
− | <!-- Zwei Divs nebeneinander - Hier kann man Bilder oder articles einfuegen -->
| + | <!-- Zwei Divs nebeneinander - Hier kann man Bilder oder articles einfuegen --> |
− | <div class="contentline">
| + | <div class="contentline"> |
− | <div class="half left">
| + | <div class="half left"> |
− | <!-- Mittleres zentriertes Bild -->
| + | <!-- Mittleres zentriertes Bild --> |
− | <div class="figure medium">
| + | <div class="figure medium"> |
− | <img class="figure image" src="https://static.igem.org/mediawiki/2017/4/4c/T--Bielefeld-CeBiTec--MAX_Fig2.png">
| + | <img class="figure image" src="https://static.igem.org/mediawiki/2017/4/4c/T--Bielefeld-CeBiTec--MAX_Fig2.png"> |
− | <p class="figure subtitle"><b>Figure 2:</b> Native DNA PAGE of annealed mutA oligos. Samples: UBP_target ssDNA, UBP_target annealing, restricted UBP_target (<i>Eci</i>I), restricted mutA (<i>Eci</i>I), ssDNA oligo, annealed mutA.</p>
| + | <p class="figure subtitle"><b>Figure 2:</b> Native DNA PAGE of annealed mutA oligos. Samples: UBP_target ssDNA, UBP_target annealing, restricted UBP_target (<i>Eci</i>I), restricted mutA (<i>Eci</i>I), ssDNA oligo, annealed mutA.</p> |
− | </div>
| + | </div> |
− | </div>
| + | </div> |
− | <div class="half right">
| + | <div class="half right"> |
− | <!-- Mittleres zentriertes Bild -->
| + | <!-- Mittleres zentriertes Bild --> |
− | <div class="figure medium">
| + | <div class="figure medium"> |
− | <img class="figure image" src="https://static.igem.org/mediawiki/2017/9/90/T--Bielefeld-CeBiTec--MAX_Fig3.png">
| + | <img class="figure image" src="https://static.igem.org/mediawiki/2017/9/90/T--Bielefeld-CeBiTec--MAX_Fig3.png"> |
− | <p class="figure subtitle"><b>Figure 3:</b> Native DNA PAGE of annealed oligos. Samples: annealed mutT, ssDNA oligo, restricted mutT (<i>Bsa</i>I), restricted UBP_target (<i>Sap</i>I), UBP_target annealing, UBP_target ssDNA.</p>
| + | <p class="figure subtitle"><b>Figure 3:</b> Native DNA PAGE of annealed oligos. Samples: annealed mutT, ssDNA oligo, restricted mutT (<i>Bsa</i>I), restricted UBP_target (<i>Sap</i>I), UBP_target annealing, UBP_target ssDNA.</p> |
− | </div>
| + | </div> |
− | </div>
| + | </div> |
− | </div>
| + | </div> |
− |
| + | |
− | <!-- Zwei Divs nebeneinander - Hier kann man Bilder oder articles einfuegen -->
| + | <!-- Zwei Divs nebeneinander - Hier kann man Bilder oder articles einfuegen --> |
− | <div class="contentline">
| + | <div class="contentline"> |
− | <div class="half left">
| + | <div class="half left"> |
− | <!-- Mittleres zentriertes Bild -->
| + | <!-- Mittleres zentriertes Bild --> |
− | <div class="figure medium">
| + | <div class="figure medium"> |
− | <img class="figure image" src="https://static.igem.org/mediawiki/2017/2/2b/T--Bielefeld-CeBiTec--MAX_Fig4.png">
| + | <img class="figure image" src="https://static.igem.org/mediawiki/2017/2/2b/T--Bielefeld-CeBiTec--MAX_Fig4.png"> |
− | <p class="figure subtitle"><b>Figure 4:</b> Native DNA PAGE of annealed mutG oligos. Samples: UBP_target ssDNA, UBP_target annealing, restricted UBP_target (<i>Sap</i>I) restricted mutG (<i>Sap</i>I), ssDNA oligo, annealed mutG.</p>
| + | <p class="figure subtitle"><b>Figure 4:</b> Native DNA PAGE of annealed mutG oligos. Samples: UBP_target ssDNA, UBP_target annealing, restricted UBP_target (<i>Sap</i>I) restricted mutG (<i>Sap</i>I), ssDNA oligo, annealed mutG.</p> |
− | </div>
| + | </div> |
− | </div>
| + | </div> |
− | <div class="half right">
| + | <div class="half right"> |
− | <!-- Mittleres zentriertes Bild -->
| + | <!-- Mittleres zentriertes Bild --> |
− | <div class="figure medium">
| + | <div class="figure medium"> |
− | <img class="figure image" src="https://static.igem.org/mediawiki/2017/c/c8/T--Bielefeld-CeBiTec--MAX_Fig5.png">
| + | <img class="figure image" src="https://static.igem.org/mediawiki/2017/c/c8/T--Bielefeld-CeBiTec--MAX_Fig5.png"> |
− | <p class="figure subtitle"><b>Figure 5:</b> Native DNA PAGE of annealed mutC oligos. Samples: UBP_target ssDNA, UBP_target annealing, restricted UBP_target (<i>Mnl</i>I) restricted mutC (<i>Mnl</i>I), ssDNA oligo, annealed mutC.</p>
| + | <p class="figure subtitle"><b>Figure 5:</b> Native DNA PAGE of annealed mutC oligos. Samples: UBP_target ssDNA, UBP_target annealing, restricted UBP_target (<i>Mnl</i>I) restricted mutC (<i>Mnl</i>I), ssDNA oligo, annealed mutC.</p> |
− | </div>
| + | </div> |
− | </div>
| + | </div> |
− | </div>
| + | </div> |
− | <br>Figures 2 - 5 show the expected band pattern, although the digest of the M.A.X targets is not complete. Later experiments revealed that a longer incubation time is necessary.
| + | <br>Figures 2 - 5 show the expected band pattern, although the digest of the M.A.X targets is not complete. Later experiments revealed that a longer incubation time is necessary. |
− | The M.A.X targets are digested after 40 bp, while the UBP_target which contains the unnatuarl bases is still of full length because the recognition site of the restriction enzyme is interrupted by the UBP.
| + | The M.A.X targets are digested after 40 bp, while the UBP_target which contains the unnatuarl bases is still of full length because the recognition site of the restriction enzyme is interrupted by the UBP. |
− | In Figure 5, the UBP_target shows a restricted band pattern because of the second <i>Mnl</i>I restriction site just 4 bases next to the first one. It is hard to see, but the UBP_target fragment is a little bit longer
| + | In Figure 5, the UBP_target shows a restricted band pattern because of the second <i>Mnl</i>I restriction site just 4 bases next to the first one. It is hard to see, but the UBP_target fragment is a little bit longer |
− | than the restriction fragment of mutC.The UBP_target annealings are not unexpected digested, indicating that the UBP prevents sequence recognition of the tested restriction enzymes. This proofs that the M.A.X restriction system is a
| + | than the restriction fragment of mutC.The UBP_target annealings are not unexpected digested, indicating that the UBP prevents sequence recognition of the tested restriction enzymes. This proofs that the M.A.X restriction system is a |
− | good detection system for UBP retention and mutation event analysis in selected DNA sequences.
| + | good detection system for UBP retention and mutation event analysis in selected DNA sequences. |
− | </br>
| + | </br> |
− |
| + | |
− |
| + | |
− |
| + | |
− |
| + | |
− | </article>
| + | </article> |
| | | |
| | | |
Line 193: |
Line 193: |
| </div> | | </div> |
| <div class="contentbox"> | | <div class="contentbox"> |
− | <div class="content">
| + | <div class="content"> |
− |
| + | |
− | <!-- Ueberschriften -->
| + | <!-- Ueberschriften --> |
− |
| + | |
− | <h3> PCR with UBPs </h3>
| + | <h3> PCR with UBPs </h3> |
− |
| + | |
− |
| + | |
− | <!-- Normaler Text -->
| + | <!-- Normaler Text --> |
− | <article>
| + | <article> |
− | <br>Based on Sismour <i>et al</i>. (2005) and Johnson <i>et al.</i> (2004), we designed a novel protocol for PCR with the unnatural base pair isoG and isoC<sup>m</sup>. We first started to reproduce positive results with <a target="_blank"href="https://static.igem.org/mediawiki/2017/1/14/T--Bielefeld-CeBiTec--CMZ-PCRwithUBP.pdf">Titanium Taq (TiTaq) polymerase</a>. While Johnson <i>et al.</i> presented an efficiency of 96 % ± 3 %, Sismour <i>et al.</i> showed a reduced fidelity using the Klenow fragment of TiTaq polymerase. Without thymidine analogues, the fidelity per round PCR decreases rapidly to less than 60 % after 20 rounds of PCR. </br>
| + | <br>Based on Sismour <i>et al</i>. (2005) and Johnson <i>et al.</i> (2004), we designed a novel protocol for PCR with the unnatural base pair isoG and isoC<sup>m</sup>. We first started to reproduce positive results with <a target="_blank"href="https://static.igem.org/mediawiki/2017/1/14/T--Bielefeld-CeBiTec--CMZ-PCRwithUBP.pdf">Titanium Taq (TiTaq) polymerase</a>. While Johnson <i>et al.</i> presented an efficiency of 96 % ± 3 %, Sismour <i>et al.</i> showed a reduced fidelity using the Klenow fragment of TiTaq polymerase. Without thymidine analogues, the fidelity per round PCR decreases rapidly to less than 60 % after 20 rounds of PCR. </br> |
− | <br>For endpoint determination, we performed PCR reactions with 30 rounds to find out if there is any polymerase activity with template DNA containing the unnatural bases isoG and isoC<sup>m</sup>.
| + | <br>For endpoint determination, we performed PCR reactions with 30 rounds to find out if there is any polymerase activity with template DNA containing the unnatural bases isoG and isoC<sup>m</sup>. |
− | </br>
| + | </br> |
− | <br> The PCR templates were prepared by ligating each of the annealed 80 bp M.A.X targets mutA, mutT, mutG and mutC into pSB1C3_RuBisCo <a href=" http://parts.igem.org/Part:BBa_K1465202"> (BBa_K1465202) </a>. For this purpose, the plasmid backbone was linearized by digestion with <i>Bmt</i>I and <i>Xba</i>I. For complementary sticky ends, the annealed oligos were digested with <i>Bmt</i>I and <i>Spe</i>I. After ligation, subsequent digestion with <i>Xba</i>I, lambda exonuclease and exonuclease I was performed to reduce the amount of unintended DNA template.
| + | <br> The PCR templates were prepared by ligating each of the annealed 80 bp M.A.X targets mutA, mutT, mutG and mutC into pSB1C3_RuBisCo <a href=" http://parts.igem.org/Part:BBa_K1465202"> (BBa_K1465202) </a>. For this purpose, the plasmid backbone was linearized by digestion with <i>Bmt</i>I and <i>Xba</i>I. For complementary sticky ends, the annealed oligos were digested with <i>Bmt</i>I and <i>Spe</i>I. After ligation, subsequent digestion with <i>Xba</i>I, lambda exonuclease and exonuclease I was performed to reduce the amount of unintended DNA template. |
− | </br>
| + | </br> |
− | <!-- Grosses zentriertes Bild -->
| + | <!-- Grosses zentriertes Bild --> |
− | <div class="figure medium">
| + | <div class="figure medium"> |
− | <img class="figure image" src="https://static.igem.org/mediawiki/2017/f/fa/T--Bielefeld-CeBiTec--pSB1C3_Rubisco_Fig6.png">
| + | <img class="figure image" src="https://static.igem.org/mediawiki/2017/f/fa/T--Bielefeld-CeBiTec--pSB1C3_Rubisco_Fig6.png"> |
− | <p class="figure subtitle"><b>Figure 6: Plasmidcard of pSB1C3_RuBisCo which is used as backbone <a target="_blank"href="http://parts.igem.org/Part:BBa_K1465202">(BBa_K1465202)</a> for M.A.X targets and UBP_target during PCR.</b> It has a chloramphenicol resistance and a length of 2517 bp. Each construct contains a different M.A.X target insert (mutA, muT, mutG, mutC) or UBP_target and is 351 bp long. </p>
| + | <p class="figure subtitle"><b>Figure 6: Plasmidcard of pSB1C3_RuBisCo which is used as backbone <a target="_blank"href="http://parts.igem.org/Part:BBa_K1465202">(BBa_K1465202)</a> for M.A.X targets and UBP_target during PCR.</b> It has a chloramphenicol resistance and a length of 2517 bp. Each construct contains a different M.A.X target insert (mutA, muT, mutG, mutC) or UBP_target and is 351 bp long. </p> |
− | </div>
| + | </div> |
− | <br>To increase the possibility of the insertion of the unnatural bases, we used 100 µM dNTPs and 200 µM isoG and 200 µM isoC<sup>m</sup> for each reaction. After variations of template concentrations from 1 ng µL<sup>-1</sup> to 50 ng µL<sup>-1</sup>, the best concentrations to acquire high-quality bands were 1 ng µL<sup>-1</sup> for the M.A.X targets and 25 ng µL<sup>-1</sup> for the UBP_target template. </br>
| + | <br>To increase the possibility of the insertion of the unnatural bases, we used 100 µM dNTPs and 200 µM isoG and 200 µM isoC<sup>m</sup> for each reaction. After variations of template concentrations from 1 ng µL<sup>-1</sup> to 50 ng µL<sup>-1</sup>, the best concentrations to acquire high-quality bands were 1 ng µL<sup>-1</sup> for the M.A.X targets and 25 ng µL<sup>-1</sup> for the UBP_target template. </br> |
− | <!-- Mittleres zentriertes Bild -->
| + | <!-- Mittleres zentriertes Bild --> |
− | <div class="figure medium">
| + | <div class="figure medium"> |
− | <img class="figure image" src="https://static.igem.org/mediawiki/2017/1/17/T--Bielefeld-CeBiTec--UBP_PCR_Fig7.png">
| + | <img class="figure image" src="https://static.igem.org/mediawiki/2017/1/17/T--Bielefeld-CeBiTec--UBP_PCR_Fig7.png"> |
− | <p class="figure subtitle"><b>Figure 7: PCR with Titanium Taq polymerase of pSB1C3_RuBisCo </b> with the inserts mutA, mutT, mutG, mutC (5 ng µL<sup>-1</sup>) and UBP_target (25 ng µL<sup>-1</sup>). The expected fragment is 351 bp long. </p>
| + | <p class="figure subtitle"><b>Figure 7: PCR with Titanium Taq polymerase of pSB1C3_RuBisCo </b> with the inserts mutA, mutT, mutG, mutC (5 ng µL<sup>-1</sup>) and UBP_target (25 ng µL<sup>-1</sup>). The expected fragment is 351 bp long. </p> |
− | </div>
| + | </div> |
− | <br>To quantify the efficiency of the incorporation of isoG and isoC<sup>m</sup>, all PCR products were tested/restricted with the M.A.X system. In order to achieve complete digestion, different incubation times from 1 h to 15 h were tested. The best results with <i>Bsa</i>I and <i>Mnl</i>I were achieved with an incubation of 15 h overnight. For the less stable enzymes <i>Eci</i>I and <i>Sap</i>I, a 2 h digestion with an addition of further enzyme after 1 h turned out to be optimal. Nevertheless, <i>Eci</i>I and <i>Sap</i>I could not digest the complete sample even if the concentrations are lowered. Therefore, we expected undigested bands in the M.A.X targets mutA and mutG for the whole experiment. </br>
| + | <br>To quantify the efficiency of the incorporation of isoG and isoC<sup>m</sup>, all PCR products were tested/restricted with the M.A.X system. In order to achieve complete digestion, different incubation times from 1 h to 15 h were tested. The best results with <i>Bsa</i>I and <i>Mnl</i>I were achieved with an incubation of 15 h overnight. For the less stable enzymes <i>Eci</i>I and <i>Sap</i>I, a 2 h digestion with an addition of further enzyme after 1 h turned out to be optimal. Nevertheless, <i>Eci</i>I and <i>Sap</i>I could not digest the complete sample even if the concentrations are lowered. Therefore, we expected undigested bands in the M.A.X targets mutA and mutG for the whole experiment. </br> |
| | | |
− | <br>After the first successful PCR, we tested if the presence of isoG and isoC<sup>m</sup> has any influence on the efficiency of the polymerase. So, we added both unnatural bases to every PCR reaction with the M.A.X targets as template to see if the intensity of the bands decreases.<br>
| + | <br>After the first successful PCR, we tested if the presence of isoG and isoC<sup>m</sup> has any influence on the efficiency of the polymerase. So, we added both unnatural bases to every PCR reaction with the M.A.X targets as template to see if the intensity of the bands decreases.<br> |
| | | |
− | <!-- Grosses zentriertes Bild -->
| + | <!-- Grosses zentriertes Bild --> |
− | <div class="figure large">
| + | <div class="figure large"> |
− | <img class="figure image" src="https://static.igem.org/mediawiki/2017/0/0b/T--Bielefeld-CeBiTec--PCR-UBP-A-H.png">
| + | <img class="figure image" src="https://static.igem.org/mediawiki/2017/0/0b/T--Bielefeld-CeBiTec--PCR-UBP-A-H.png"> |
− | <p class="figure subtitle"><b>Figure 9: PCRs</b> with Titanium Taq (<b>A</b>), Go Taq G2 (<b>B</b>), Allin HiFi DNA Polymerase (<b>C</b>), innuDRY polymerase (<b>D</b>), BioMaster-HS Taq PCR polymerase (<b>E</b>), FirePol DNA polymerase (<b>F</b>), Phusion DNA polymerase (<b>G</b>) and Q5 DNA polymerase (<b>H</b>). The template is pSB1C3_RuBisCo with the inserts mutA, mutT, mutG, mutC (5 ng µL<sup>-1</sup>) and UBP_target (25 ng µL<sup>-1</sup>) after the restriction digest with <i>Eci</i>I (mutA) and <i>Sap</i>I (mutG) for 2 h and <i>Bsa</i>I (mutT) and <i>Mnl</i>I (mutC) for 15 h.</p>
| + | <p class="figure subtitle"><b>Figure 9: PCRs</b> with Titanium Taq (<b>A</b>), Go Taq G2 (<b>B</b>), Allin HiFi DNA Polymerase (<b>C</b>), innuDRY polymerase (<b>D</b>), BioMaster-HS Taq PCR polymerase (<b>E</b>), FirePol DNA polymerase (<b>F</b>), Phusion DNA polymerase (<b>G</b>) and Q5 DNA polymerase (<b>H</b>). The template is pSB1C3_RuBisCo with the inserts mutA, mutT, mutG, mutC (5 ng µL<sup>-1</sup>) and UBP_target (25 ng µL<sup>-1</sup>) after the restriction digest with <i>Eci</i>I (mutA) and <i>Sap</i>I (mutG) for 2 h and <i>Bsa</i>I (mutT) and <i>Mnl</i>I (mutC) for 15 h.</p> |
− | </div>
| + | </div> |
− |
| + | |
− | <br>The native fragments of the PCRs are as expected 351 bp long as can be seen in Figure 8. We always used the same template concentration and the same primers to ensure the comparability between the DNA polymerases. As can be seen in Figure 8, all Taq based polymerases are able to incorporate the unnatural base pair in the DNA.</br>
| + | <br>The native fragments of the PCRs are as expected 351 bp long as can be seen in Figure 8. We always used the same template concentration and the same primers to ensure the comparability between the DNA polymerases. As can be seen in Figure 8, all Taq based polymerases are able to incorporate the unnatural base pair in the DNA.</br> |
| <br>The best results were apparently achieved with the Go Taq G2 DNA polymerase (Figure 8 <b>B</b>). All lanes with the UBPs show clear bands and no mutations to T or A. The M.A.X restriction digest showed there are some mutations to C or the antisense strand mutated to G and was paired with a C, which caused the completed recognition site of <i>Mnl</i>I.</br> | | <br>The best results were apparently achieved with the Go Taq G2 DNA polymerase (Figure 8 <b>B</b>). All lanes with the UBPs show clear bands and no mutations to T or A. The M.A.X restriction digest showed there are some mutations to C or the antisense strand mutated to G and was paired with a C, which caused the completed recognition site of <i>Mnl</i>I.</br> |
| <br>Every PCR product of the UBP_target fragment was digested because of the second <i>Mnl</i>I restriction site, but differences can be shown between the M.A.X target mutC and the UBP_target PCR product because of the distance between both restriction sites.</br> | | <br>Every PCR product of the UBP_target fragment was digested because of the second <i>Mnl</i>I restriction site, but differences can be shown between the M.A.X target mutC and the UBP_target PCR product because of the distance between both restriction sites.</br> |
Line 234: |
Line 234: |
| | | |
| <!-- Tabelle mit Tabellenueberschrift | | <!-- Tabelle mit Tabellenueberschrift |
− | Soviele Spalten wie es geben soll, so viele <th>'s muessen im thead und <td>'s -->
| + | Soviele Spalten wie es geben soll, so viele <th>'s muessen im thead und <td>'s --> |
− | <p class="table-headline"><b>Table 2:</b> Used polymerases with specific modifications during the PCRs with isoG and isoC<sup>m</sup>.</p>
| + | <p class="table-headline"><b>Table 2:</b> Used polymerases with specific modifications during the PCRs with isoG and isoC<sup>m</sup>.</p> |
− | <table>
| + | <table> |
− | <thead>
| + | <thead> |
− | <tr>
| + | <tr> |
− | <th style="width: auto">Position in Figure 9</th>
| + | <th style="width: auto">Position in Figure 9</th> |
− | <th style="width: auto">DNA polymerase</th>
| + | <th style="width: auto">DNA polymerase</th> |
− | <th style="width: auto">Distributor</th>
| + | <th style="width: auto">Distributor</th> |
− | <th style="width: auto">Modification</th>
| + | <th style="width: auto">Modification</th> |
− | <th style="width: auto">Incorporation of UBP?</th>
| + | <th style="width: auto">Incorporation of UBP?</th> |
− | </tr>
| + | </tr> |
− | </thead>
| + | </thead> |
− | <tbody>
| + | <tbody> |
− | <tr>
| + | <tr> |
− | <td align="center">A</td>
| + | <td align="center">A</td> |
− | <td align="left"><a target="_blank"href="http://www.clontech.com/DE/Products/PCR/High_Yield_PCR/Titanium_Taq_DNA_Polymerase?sitex=10024:22372:US">Titanium Taq</a></td>
| + | <td align="left"><a target="_blank"href="http://www.clontech.com/DE/Products/PCR/High_Yield_PCR/Titanium_Taq_DNA_Polymerase?sitex=10024:22372:US">Titanium Taq</a></td> |
− | <td align="left">Clontech</td>
| + | <td align="left">Clontech</td> |
− | <td align="left">Lacks 5'-exonuclease activity</td>
| + | <td align="left">Lacks 5'-exonuclease activity</td> |
− | <td align="center">yes</td>
| + | <td align="center">yes</td> |
− |
| + | |
− |
| + | |
− | </tr>
| + | </tr> |
− |
| + | |
− | <tr>
| + | <tr> |
− | <td align="center">B</td>
| + | <td align="center">B</td> |
− | <td align="left"> <a target="_blank"href="https://www.promega.de/products/pcr/endpoint-pcr/gotaq-g2-dna-polymerase/?catNum=M7841">GoTaq G2</a></td>
| + | <td align="left"> <a target="_blank"href="https://www.promega.de/products/pcr/endpoint-pcr/gotaq-g2-dna-polymerase/?catNum=M7841">GoTaq G2</a></td> |
− | <td align="left">Promega</td>
| + | <td align="left">Promega</td> |
− | <td align="left">Has 5’-3’ exonuclease activity</td>
| + | <td align="left">Has 5’-3’ exonuclease activity</td> |
− | <td align="center">yes</td>
| + | <td align="center">yes</td> |
− |
| + | |
− |
| + | |
− | </tr>
| + | </tr> |
− |
| + | |
− | <tr>
| + | <tr> |
− | <td align="center">C</td>
| + | <td align="center">C</td> |
− | <td align="left"><a target="_blank"href="https://www.highqu.com/allintmhifi-dna-polymerase-2-u-l.html">Allin HiFi</a> </td>
| + | <td align="left"><a target="_blank"href="https://www.highqu.com/allintmhifi-dna-polymerase-2-u-l.html">Allin HiFi</a> </td> |
− | <td align="left">highQu</td>
| + | <td align="left">highQu</td> |
− | <td align="left">Derived from <i>Pfu</i> polymerase with several mutations and proof reading function.</td>
| + | <td align="left">Derived from <i>Pfu</i> polymerase with several mutations and proof reading function.</td> |
− | <td align="center">yes</td>
| + | <td align="center">yes</td> |
− |
| + | |
− |
| + | |
− | </tr>
| + | </tr> |
− |
| + | |
− | <tr>
| + | <tr> |
− | <td align="center">D</td>
| + | <td align="center">D</td> |
− | <td align="left"><a target="_blank"href="https://www.analytik-jena.de/fileadmin/content/import/imported_dam/br_Product_Guide_Reagents_Plastic_WEB_geschuetzt.pdf">innuDRY </a></td>
| + | <td align="left"><a target="_blank"href="https://www.analytik-jena.de/fileadmin/content/import/imported_dam/br_Product_Guide_Reagents_Plastic_WEB_geschuetzt.pdf">innuDRY </a></td> |
− | <td align="left">Analytik Jena</td>
| + | <td align="left">Analytik Jena</td> |
− | <td align="left">Specific hot-start Taq DNA polymerase.</td>
| + | <td align="left">Specific hot-start Taq DNA polymerase.</td> |
− | <td align="center">yes</td>
| + | <td align="center">yes</td> |
− |
| + | |
− |
| + | |
− | </tr>
| + | </tr> |
− |
| + | |
− | <tr>
| + | <tr> |
− | <td align="center">E</td>
| + | <td align="center">E</td> |
− | <td align="left"><a target="_blank"href=" http://biolabmix.ru/en/products/klassicheskaja_pcr/biomaster_hs-taq_pcr-color__2_/"> BioMaster-HS Taq </a></td>
| + | <td align="left"><a target="_blank"href=" http://biolabmix.ru/en/products/klassicheskaja_pcr/biomaster_hs-taq_pcr-color__2_/"> BioMaster-HS Taq </a></td> |
− | <td align="left">Biolabmix</td>
| + | <td align="left">Biolabmix</td> |
− | <td align="left">Hot-Start <i>Taq</i> DNA polymerase</td>
| + | <td align="left">Hot-Start <i>Taq</i> DNA polymerase</td> |
− | <td align="center">yes</td>
| + | <td align="center">yes</td> |
− |
| + | |
− |
| + | |
− | </tr>
| + | </tr> |
− |
| + | |
− | <tr>
| + | <tr> |
− | <td align="center">F</td>
| + | <td align="center">F</td> |
− | <td align="left"><a target="_blank"href=" https://www.sbd.ee/EN/products/pcr/firepol "> FirePol </a></td>
| + | <td align="left"><a target="_blank"href=" https://www.sbd.ee/EN/products/pcr/firepol "> FirePol </a></td> |
− | <td align="left">Solis Biodyne</td>
| + | <td align="left">Solis Biodyne</td> |
− | <td align="left">Has a 5’-3’ polymerization-dependent exonuclease replacement, but lacks 3’-5’ exonuclease activity</td>
| + | <td align="left">Has a 5’-3’ polymerization-dependent exonuclease replacement, but lacks 3’-5’ exonuclease activity</td> |
− | <td align="center">yes</td>
| + | <td align="center">yes</td> |
− |
| + | |
− |
| + | |
− | </tr>
| + | </tr> |
− |
| + | |
− | <tr>
| + | <tr> |
− | <td align="center">G</td>
| + | <td align="center">G</td> |
− | <td align="left"><a target="_blank"href="https://www.neb.com/products/m0531-phusion-high-fidelity-pcr-master-mix-with-hf-buffer#Product%20Information">Phusion</a></td>
| + | <td align="left"><a target="_blank"href="https://www.neb.com/products/m0531-phusion-high-fidelity-pcr-master-mix-with-hf-buffer#Product%20Information">Phusion</a></td> |
− | <td align="left">NEB</td>
| + | <td align="left">NEB</td> |
− | <td align="left">Derived <i>Pyrococcus</i> enzyme fused with a processivity-enhancing domain. It possesses 5’-3’ polymerase activity and 3’-5’ exonuclease.</td>
| + | <td align="left">Derived <i>Pyrococcus</i> enzyme fused with a processivity-enhancing domain. It possesses 5’-3’ polymerase activity and 3’-5’ exonuclease.</td> |
− | <td align="center">yes</td>
| + | <td align="center">yes</td> |
− |
| + | |
− |
| + | |
− | </tr>
| + | </tr> |
− |
| + | |
− | <tr>
| + | <tr> |
− | <td align="center">H</td>
| + | <td align="center">H</td> |
− | <td align="left"><a target="_blank"href="https://www.neb.com/products/m0491-q5-high-fidelity-dna-polymerase#Product%20Information">Q5</a></td>
| + | <td align="left"><a target="_blank"href="https://www.neb.com/products/m0491-q5-high-fidelity-dna-polymerase#Product%20Information">Q5</a></td> |
− | <td align="left">NEB</td>
| + | <td align="left">NEB</td> |
− | <td align="left">Fused to the processivity-enhancing Sso7d DNA binding domain with an error rate ~280-fold lower than of <i>Taq</i> DNA polymerase</td>
| + | <td align="left">Fused to the processivity-enhancing Sso7d DNA binding domain with an error rate ~280-fold lower than of <i>Taq</i> DNA polymerase</td> |
− | <td align="center">No</td>
| + | <td align="center">No</td> |
− |
| + | |
− |
| + | |
− | </tr>
| + | </tr> |
− |
| + | |
− |
| + | |
− |
| + | |
− | </tbody>
| + | </tbody> |
− | </table>
| + | </table> |
− |
| + | |
− |
| + | |
− |
| + | |
− |
| + | |
− |
| + | |
− |
| + | |
− |
| + | |
− |
| + | |
− | <br>We always used the same template concentration and the same primers to ensure the comparability between the DNA polymerases. As can be seen in the figures above, all Taq based polymerases are able to incorporate the unnatural base pair in the DNA. The best results were apparently achieved with the Go Taq G2 DNA polymerase. All lanes with the UBPs show clear bands and no mutations to T or A. The M.A.X restriction digest showed there are some mutations to C. The PCR product of the UBP_target fragment was digested because of the second <i>Mnl</i>I restriction site, but one can see a difference between the M.A.X target mutC and the UBP_target PCR product. The digested PCR products of the BioMaster-HS Taq PCR polymerase and the Allin HiFi DNA Polymerase show more mutations to A than the other polymerases. But also the TiTaq polymerase seems to miss incorporate the A instead of isoG. Moreover, the Phusion DNA polymerase proceeds to miss the incorporated G while the Q5 DNA polymerase does not show any bands containing the UBPs. Both polymerases have a proofreading function in contrast to the other polymerases.
| + | <br>We always used the same template concentration and the same primers to ensure the comparability between the DNA polymerases. As can be seen in the figures above, all Taq based polymerases are able to incorporate the unnatural base pair in the DNA. The best results were apparently achieved with the Go Taq G2 DNA polymerase. All lanes with the UBPs show clear bands and no mutations to T or A. The M.A.X restriction digest showed there are some mutations to C. The PCR product of the UBP_target fragment was digested because of the second <i>Mnl</i>I restriction site, but one can see a difference between the M.A.X target mutC and the UBP_target PCR product. The digested PCR products of the BioMaster-HS Taq PCR polymerase and the Allin HiFi DNA Polymerase show more mutations to A than the other polymerases. But also the TiTaq polymerase seems to miss incorporate the A instead of isoG. Moreover, the Phusion DNA polymerase proceeds to miss the incorporated G while the Q5 DNA polymerase does not show any bands containing the UBPs. Both polymerases have a proofreading function in contrast to the other polymerases. |
− | </br>
| + | </br> |
− | <br>In the final analysis, the faster and the stronger the poof reading function of a polymerase is, the worse is the incorporation of the UBPs.
| + | <br>In the final analysis, the faster and the stronger the poof reading function of a polymerase is, the worse is the incorporation of the UBPs. |
− | </br>
| + | </br> |
− | <br>The M.A.X system seems to be a good method for the first review of the efficiency of the polymerases. One can see if there is any incorporation of UBPs, so that sequencing is worthwhile. Minor deviations are not detectable by gel electrophoresis. It is also difficult to make a clear statement about the proportion of correctly or incorrectly incorporated unnatural bases, because the digested fragments seem to be less intensive than intact sequences.
| + | <br>The M.A.X system seems to be a good method for the first review of the efficiency of the polymerases. One can see if there is any incorporation of UBPs, so that sequencing is worthwhile. Minor deviations are not detectable by gel electrophoresis. It is also difficult to make a clear statement about the proportion of correctly or incorrectly incorporated unnatural bases, because the digested fragments seem to be less intensive than intact sequences. |
− | </br>
| + | </br> |
− |
| + | |
− |
| + | |
− |
| + | |
− | </article>
| + | </article> |
− |
| + | |
− |
| + | |
− |
| + | |
− |
| + | |
− | </div>
| + | </div> |
| </div> | | </div> |
| | | |
Line 497: |
Line 497: |
| </div> | | </div> |
| | | |
| + | </div> |
| + | <div class="bevel bl"></div> |
| + | </div> |
| | | |
| | | |
| + | |
| + | <div class="contentbox"> |
| + | <div class="bevel tr"></div> |
| + | <div class="content"> |
| + | |
| + | <div class="figure medium"> |
| + | <img class="figure image" src="https://static.igem.org/mediawiki/2017/0/04/T--Bielefeld-CeBiTec--PCR_MAX_iCG.png"> |
| + | <p class="figure subtitle"> |
| + | <b>Fig. 5: PCR of DNA containing isoG/isoC<sup>m</sup> with GoTaq analyzed with iCG and M.A.X.</b> A DNA template containing an unnatural base pair between isoG and isoC<sup>m</sup> was analyzed in an orthogonal approach with M.A.X. and iCG. |
| + | </p> |
| + | </div> |
| | | |
| </div> | | </div> |
| <div class="bevel bl"></div> | | <div class="bevel bl"></div> |
| </div> | | </div> |
| + | |
| | | |
| | | |
Line 547: |
Line 562: |
| | | |
| | | |
− |
| + | |
− |
| + | |
− | </div>
| + | </div> |
| </div> | | </div> |
− | </div> | + | </div> |
| </body> | | </body> |
| <script> | | <script> |